dry eye disease

Allergan Submits Prior Approval Supplement For Restasis
Bidness, ETC
Wed, 11/11/15 - 09:58 am
Allergan
Restasis
dry eye disease
Shire says its once-rejected eye drug is back on track with a Phase III success
Fierce Biotech
Tue, 10/27/15 - 09:42 am
Shire
Lifitegrast
dry eye disease
Shire Aims to Refile Blockbuster Eye Drug in First Quarter
Bloomberg
Mon, 10/19/15 - 09:59 am
Shire
dry eye disease
Lifitegrast
Allergan closes $125m Oculeve buy
Mass Device
Tue, 08/11/15 - 06:50 pm
Allergan
Oculeve
M&A
devices
dry eye disease
OD-01
Allergan to drop $125m on Oculeve
Mass Device
Mon, 07/6/15 - 08:41 pm
Allergan
Oculeve
devices
OD-01
dry eye disease
Eleven Bio's Shares Routed as Dry Eye Drug Flunks Phase 3 Test
Xconomy
Mon, 05/18/15 - 09:05 am
Eleven Biotherapeutics
dry eye disease
EBI-005
Shire nabs priority review for potential blockbuster dry eye drug
BioPharma Dive
Fri, 04/10/15 - 10:48 am
Shire
dry eye disease
Lifitegrast
Rigel experimental eye drug fails mid-stage study
Yahoo/Reuters
Wed, 08/13/14 - 08:23 am
Rigel Pharmaceuticals
R348
dry eye disease
RegeneRx’s Strategic Partner G-treeBNT Preparing for Phase III Dry Eye Trials in Asia with RGN-259
Yahoo
Mon, 07/7/14 - 10:55 am
RegeneRx
G-treeBNT
dry eye disease
RGN-259
Asia
Shire to submit dry eye treatment to U.S. drug regulator
Yahoo/Reuters
Fri, 05/16/14 - 03:45 pm
Shire
dry eye disease
Lifitegrast
Shire says new dry-eye drug fails to meet trial goal
Yahoo/Reuters
Wed, 04/30/14 - 10:23 am
Shire
dry eye disease
Lifitegrast
Allergan Slips on Restasis Challenge
Yahoo/Zacks.com
Thu, 01/23/14 - 05:54 pm
Allergan
Restasis
dry eye disease
Actavis
generics
Third Rock's Eleven pitches a $69M IPO to fuel its PhIII dry eye program
Fierce Biotech
Tue, 12/31/13 - 11:40 am
dry eye disease
Third Rock
IPOs
Eleven Biotherapeutics
OphthaliX’s dry eye drug fails endpoint in Phase III study
Pharmaceutical Business Review
Mon, 12/30/13 - 12:10 pm
OphthaliX
dry eye disease
CF101
Shire's new dry eye drug disappoints in pivotal trial
Yahoo/Reuters
Fri, 12/6/13 - 09:04 am
Shire
dry eye disease
Lifitegrast
Allergan pushes FDA to defend Restasis from early generics
Fierce Pharma
Wed, 08/21/13 - 10:20 am
Allergan
Restasis
dry eye disease
FDA
generics
For Allergan Shareholders, Will it Be Dry Eyes or Tears of Joy?
Motley Fool
Fri, 06/28/13 - 10:26 am
Allergan
Restasis
dry eye disease
OphthaliX Inc. Announces the Completion of Patient Enrollment for the Phase 3 Dry Eye Syndrome Study
Yahoo/PR Newswire
Sat, 03/16/13 - 10:44 am
OphthaliX
CF101
dry eye disease
Inspire Pharmaceuticals launches drug in Japan
Bizjournals.com
Mon, 12/13/10 - 12:18 pm
Inspire
Japan
dry eye disease
Diquas
TearLab shares soar on Medicare update
Fri, 10/8/10 - 09:58 pm
TearLab
Medicare
dry eye disease

Pages